Clinical Trials
8 trialsNCT04489888 2025-06-19
MK-3475-B10
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT02419742 2022-10-12
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
Hoffmann-La Roche
Phase 4 Completed
NCT02151149 2018-09-24
ABOUND 70+
Celgene
Phase 4 Completed
NCT02035345 2016-12-08
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
Massachusetts General Hospital
Phase 4 Terminated
NCT01317615 2016-03-30
RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
Novartis
Phase 4 Completed
NCT02319486 2015-03-30
CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma
Sun Yat-sen University
Phase 4 Completed
NCT00883675 2013-12-18
Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer
Maestro Clinical, Inc.
Phase 4 Completed
NCT01020786 2013-08-27
A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients
Eli Lilly and Company
Phase 4 Completed